KR20240090982A - 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 - Google Patents
이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 Download PDFInfo
- Publication number
- KR20240090982A KR20240090982A KR1020247017445A KR20247017445A KR20240090982A KR 20240090982 A KR20240090982 A KR 20240090982A KR 1020247017445 A KR1020247017445 A KR 1020247017445A KR 20247017445 A KR20247017445 A KR 20247017445A KR 20240090982 A KR20240090982 A KR 20240090982A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- tritium
- deuterium
- hydrogen
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271411P | 2021-10-25 | 2021-10-25 | |
| US63/271,411 | 2021-10-25 | ||
| PCT/CN2022/127414 WO2023072085A1 (zh) | 2021-10-25 | 2022-10-25 | 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240090982A true KR20240090982A (ko) | 2024-06-21 |
Family
ID=86159046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247017445A Pending KR20240090982A (ko) | 2021-10-25 | 2022-10-25 | 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 |
| KR1020247017446A Pending KR20240090983A (ko) | 2021-10-25 | 2022-10-25 | 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247017446A Pending KR20240090983A (ko) | 2021-10-25 | 2022-10-25 | 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240415859A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4424695A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024539499A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240090982A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118215669A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI898161B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023072085A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045072A (zh) * | 2007-05-08 | 2007-10-03 | 胡军 | 山香圆叶提取物及其医药用途 |
| CN102617659A (zh) * | 2012-03-09 | 2012-08-01 | 中国烟草总公司郑州烟草研究院 | α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用 |
| CN102617658B (zh) * | 2012-03-09 | 2014-08-20 | 中国烟草总公司郑州烟草研究院 | β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用 |
| CN106167508A (zh) * | 2016-07-13 | 2016-11-30 | 上海应用技术学院 | 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法 |
-
2022
- 2022-10-25 JP JP2024547815A patent/JP2024539499A/ja active Pending
- 2022-10-25 CN CN202280071472.9A patent/CN118215669A/zh active Pending
- 2022-10-25 EP EP22885946.8A patent/EP4424695A4/en active Pending
- 2022-10-25 WO PCT/CN2022/127414 patent/WO2023072085A1/zh not_active Ceased
- 2022-10-25 KR KR1020247017445A patent/KR20240090982A/ko active Pending
- 2022-10-25 WO PCT/CN2022/127372 patent/WO2023072069A1/zh not_active Ceased
- 2022-10-25 US US18/704,869 patent/US20240415859A1/en active Pending
- 2022-10-25 CN CN202280071353.3A patent/CN118139869A/zh active Pending
- 2022-10-25 EP EP22885962.5A patent/EP4424694A4/en active Pending
- 2022-10-25 US US18/704,860 patent/US20250255893A1/en active Pending
- 2022-10-25 TW TW111140498A patent/TWI898161B/zh active
- 2022-10-25 JP JP2024547816A patent/JP2024541121A/ja active Pending
- 2022-10-25 KR KR1020247017446A patent/KR20240090983A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024541121A (ja) | 2024-11-06 |
| US20240415859A1 (en) | 2024-12-19 |
| TW202320806A (zh) | 2023-06-01 |
| CN118215669A (zh) | 2024-06-18 |
| KR20240090983A (ko) | 2024-06-21 |
| EP4424694A1 (en) | 2024-09-04 |
| TWI898161B (zh) | 2025-09-21 |
| WO2023072069A1 (zh) | 2023-05-04 |
| US20250255893A1 (en) | 2025-08-14 |
| CN118139869A (zh) | 2024-06-04 |
| TW202317142A (zh) | 2023-05-01 |
| EP4424695A4 (en) | 2025-10-22 |
| EP4424695A1 (en) | 2024-09-04 |
| WO2023072085A1 (zh) | 2023-05-04 |
| JP2024539499A (ja) | 2024-10-28 |
| EP4424694A4 (en) | 2026-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170349575A1 (en) | Novel chemokine cxcr1 and cxcr2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies | |
| CN117337289A (zh) | 用于治疗脑病症的四环化合物 | |
| CN118139869A (zh) | 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途 | |
| JP2024541121A5 (cg-RX-API-DMAC7.html) | ||
| CN102389434B (zh) | 一种治疗缺血性脑血管病的药物组合物及其制备方法 | |
| JP2005505548A (ja) | 神経細胞変性の病気の治療のためのβ−アドレナリン受容体拮抗薬を使用する方法 | |
| CN113603570B (zh) | 一种益母草碱冰片衍生物、制备方法及其应用 | |
| CN118613258A (zh) | 8-甲基-8-氮杂双环[3.2.1]辛-3-基3-羟基-2-苯基丙酸酯的酯 | |
| US20180289655A1 (en) | Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases | |
| CN120053443B (zh) | 金雀花碱-n-亚甲基-(5,7,4’-三羟基)异黄酮在制备治疗脑梗药物的应用 | |
| JP2024539499A5 (cg-RX-API-DMAC7.html) | ||
| RU2814327C1 (ru) | ПРИМЕНЕНИЕ СУЛЬФАТНЫХ СОЛЕЙ N-(3-(4-(3-(ДИИЗОБУТИЛАМИНО)ПРОПИЛ)ПИПЕРАЗИН-1-ИЛ)ПРОПИЛ)-1Н-БЕНЗО[d]ИМИДАЗОЛ-2-АМИНА И ИХ СОЛЬВАТОВ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ДВИГАТЕЛЬНЫХ НЕЙРОНОВ И НАРУШЕНИЙ НЕРВНО-МЫШЕЧНЫХ СОЕДИНЕНИЙ | |
| CN119569643B (zh) | 一种二级胺类局部麻醉药及其应用 | |
| CN116987091B (zh) | 用于治疗癫痫发作疾病的药物及其制备方法 | |
| CN118384156A (zh) | 一种火把花衍生物ri-695在制备治疗阿尔兹海默症药物中的应用 | |
| Zhu | Research progress on brain-derived neurotrophic factor in ocular diseases | |
| CN120501080A (zh) | 一种卒中后抑郁小鼠模型的构建方法 | |
| US9918996B2 (en) | Methods of using qiapine | |
| TWI230064B (en) | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders | |
| EP4716535A2 (en) | Boldine to reduce muscle atrophy and promote neuromuscular recovery | |
| Wang et al. | Mesenchymal stem cell therapy in autoimmune eye diseases: Focus on dry eye diseases and autoimmune uveitis | |
| CN121248702A (zh) | 一氧化氮供体型羊毛甾醇衍生物及其制备方法和应用 | |
| JP2007502863A (ja) | 認知障害の治療および認知改善の方法 | |
| CN115925628A (zh) | 青藤碱酯类衍生物及其制备方法和应用、镇痛药物 | |
| Raikova et al. | GILLES DE LA TOURETTE'S SYNDROME: CLINICAL FEATURES, DIAGNOSIS, MODERN TREATMENT METHODS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |